# Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma

**Abstract:** (Not provided in the original text, but constructed from the introduction)
Multiple myeloma (MM) is characterized by a dysregulated cytokine network, with elevated levels of inflammatory cytokines. This review focuses on the complex interplay between pro- and anti-inflammatory cytokines and their impact on MM. It summarizes the current understanding of how these cytokines influence MM cell growth, survival, and interactions with the bone marrow microenvironment.  The review also discusses potential therapeutic strategies targeting cytokines in MM.

**DOI/Reference:** Hindawi, Mediators of Inflammation, Volume 2017, Article ID 1852517, 24 pages. https://doi.org/10.1155/2017/1852517

**Authors:** Caterina Musolino, Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Giovanni Pioggia, and Sebastiano Gangemi

---

**1. OVERVIEW**

This review article discusses the role of cytokines in the pathogenesis and progression of multiple myeloma (MM). It focuses on the balance between pro-inflammatory and anti-inflammatory cytokines, and how this equilibrium (or disequilibrium) affects MM cell behavior and the bone marrow (BM) microenvironment. The review covers a wide range of cytokines, including IL-1, IL-2, IL-6, IL-10, IL-11, IL-12, IL-15, IL-16, IL-17, IL-18, IL-22, IL-23, IL-27, TNF, TGF-β, and heat-shock proteins (HSPs), highlighting their diverse and sometimes opposing effects.

---

**2. MAIN METHODOLOGY**

As a review article, this paper does not present original experimental data. It synthesizes findings from various published studies, including:

*   **In vitro studies:**  Experiments using MM cell lines and primary cells to examine cytokine production, signaling, and effects on cell growth, apoptosis, and other cellular processes.
*   **In vivo studies:** Animal models of MM (primarily mice) to investigate the role of cytokines in disease development and progression.
*   **Human studies:**  Analysis of patient samples (serum, bone marrow) to measure cytokine levels and correlate them with clinical parameters.
* **Clinical Trials**: Reporting on results from human tests.

---

**3. KEY FINDINGS**

*   **General Cytokine Dysregulation in MM:** MM is characterized by a dysregulated cytokine network, with increased levels of many inflammatory cytokines in the BM microenvironment.
*   **Pro-inflammatory Cytokines:**
    *   **IL-1:**  Promotes MM cell growth and survival; can be targeted therapeutically (e.g., anakinra).
    *   **IL-2:**  Complex role; can stimulate NK and T cells, but also promotes Tregs.
    *   **IL-6:**  A major growth and survival factor for MM cells; produced by both MM cells and the BM microenvironment.
    *   **IL-12:**  Generally has anti-tumor activity (stimulates Th1 responses), but its role in MM is complex.
    *   **IL-15:**  Can have both pro- and anti-tumor effects; promotes NK cell activity.
    *   **IL-16:**  Chemoattractant for CD4+ cells; elevated in MM.
    *   **IL-17:**  Promotes angiogenesis and bone destruction; associated with poor prognosis.
    *   **IL-18:**  Complex role; can promote angiogenesis, but also has anti-tumor effects.
    *   **IL-22:**  Can promote MM cell growth and survival.
    * **IL-23:** Promotes Th17 differentiation.
    * **IL-27**: Complex role.
    *   **TNF:**  Complex role; can promote inflammation and bone destruction, but also has anti-tumor effects; TNF signaling is important in MM.

*   **Anti-inflammatory Cytokines:**
    *   **IL-1Ra:**  Inhibits IL-1 signaling.
    *   **IL-4:**  Elevated in MM; role is complex.
    *   **IL-10:**  Generally immunosuppressive; complex role in MM.
    *   **IL-11:**  Can have both pro- and anti-inflammatory effects; implicated in bone destruction.
    *  **TGF-β:**  Potent immunosuppressive cytokine; promotes bone destruction in MM; complex role.
*   **Heat-Shock Proteins (HSPs):**  Can have both pro- and anti-inflammatory effects; HSP90 is a potential therapeutic target.

*   **Specific Findings:**
    *   Many cytokines are elevated in the serum and/or BM of MM patients.
    *   Cytokine levels often correlate with disease stage, prognosis, and response to therapy.
    *   Cytokines can influence MM cell growth, survival, drug resistance, angiogenesis, and bone destruction.
    *   The BM microenvironment plays a crucial role in supporting MM cell survival and proliferation through cytokine production.
    *   Therapeutic targeting of cytokines (e.g., with antibodies or small molecule inhibitors) has shown some promise, but results have been mixed.

---

**4. MAIN CONCLUSIONS**

The cytokine network in MM is complex and dysregulated, with both pro- and anti-inflammatory cytokines playing important roles in disease pathogenesis. Targeting specific cytokines or their signaling pathways holds therapeutic potential, but a better understanding of the intricate interplay between different cytokines and their context-dependent effects is needed to develop effective and safe treatments. The balance between pro- and anti-inflammatory cytokines is crucial, and disrupting this balance can have unintended consequences.

---

**5. STUDY HIGHLIGHTS**

*   **Comprehensive Overview:**  The review provides a broad overview of the roles of many different cytokines in MM.
*   **Focus on Balance:**  The review emphasizes the importance of the equilibrium between pro- and anti-inflammatory cytokines.
*   **Complexity and Context-Dependence:**  The review highlights the complex and context-dependent effects of cytokines, which can have both pro- and anti-tumor activities.
*   **Therapeutic Implications:**  The review discusses the potential of targeting cytokines for MM therapy, but also cautions about the potential risks.
*   **Bone Marrow Microenvironment:**  The review emphasizes the importance of the BM microenvironment in supporting MM cell survival and growth.
* **Key Concepts:**
    *   **Cytokines:** Signaling molecules that mediate communication between cells, particularly in the immune system.
    *   **Inflammation:**  A complex biological response to harmful stimuli, such as pathogens, damaged cells, or irritants.
    *   **Pro-inflammatory Cytokines:**  Cytokines that promote inflammation.
    *   **Anti-inflammatory Cytokines:**  Cytokines that suppress inflammation.
    *   **Bone Marrow Microenvironment:**  The cellular and molecular environment within the bone marrow, which supports hematopoiesis and can also influence the development of hematologic malignancies.
    * **Multiple Myeloma (MM):**  A cancer of plasma cells, a type of white blood cell that produces antibodies.